Skip to main content
Log in

Overexpression of ROMO1 and OMA1 are Potentially Biomarkers and Predict Unfavorable Prognosis in Gastric Cancer

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Purpose

One of the worst types of cancers is gastric cancer and no specific tumor marker is found in relation to it. Reactive oxygen species modulator 1 (ROMO1) and the overlapping with the M-AAA protease 1 homolog (OMA1) proteins are the most important mitochondrial membrane proteins, which are involved in modulating reactive oxygen species (ROS) production and the regulation of mitochondrial structure dynamics. If these proteins do not function properly, oxidative stress increases in the cell, and this can initiate the cancer or worsen the condition.

Methods

In this study, ROMO1 and OMA1 gene expressions in 40 fresh frozen gastric cancer tissue and healthy adjacent tissues were evaluated by real-time PCR, and some of the important parameters related to oxidative stress such as TAC, TOS, MDA, and TTG in the serum of cancer patients compared to healthy people were measured by spectrophotometric and fluorometric techniques.

Results

We observed that ROMO1 and OMA1 gene expressions in gastric cancer tissues increased compared to that in healthy adjacent tissues. In addition, oxidative stress parameters including TOS, OSI, and MDA in the serum of cancer patients have increased significantly and the parameters including TAC and TTG have decreased.

Conclusion

The results in our study represented that ROMO1 and OMA1 gene expressions in gastric cancer tissue have increased compared to that in healthy adjacent tissues, and oxidative stress levels have also increased significantly in relation to these proteins; therefore, these two proteins may be considered as an important cause of gastric cancer, and even introduced as tumor markers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Magdy M, Hussein T, Ezzat A, Gaballah A (2018) Pre-treatment peripheral neutrophil-lymphocyte ratio as a prognostic marker in gastric cancer. J Gastrointest Cancer. https://doi.org/10.1007/s12029-018-0144-x

  2. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137–50.

    Article  Google Scholar 

  3. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.

    Article  Google Scholar 

  4. Normando SRC, de Oliveira DP, Rodrigues AKSB, David Filho WJ, Fonseca FLA, Cruz FJSM, et al. Circulating free plasma tumor DNA in patients with advanced gastric cancer receiving systemic chemotherapy. BMC Clin Pathol. 2018;18(1):12.

    Article  CAS  Google Scholar 

  5. Hamakawa T, Kukita Y, Kurokawa Y, Miyazaki Y, Takahashi T, Yamasaki M, et al. Monitoring gastric cancer progression with circulating tumour DNA. Br J Cancer. 2015;112(2):352–6.

    Article  CAS  Google Scholar 

  6. Shimada H, Noie T, Ohashi M, Oba K, Takahashi Y. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer. 2014;17(1):26–33.

    Article  CAS  Google Scholar 

  7. Lee S, Park YH, Chung JS, Yoo YD. Romo1 and the NF-κB pathway are involved in oxidative stress-induced tumor cell invasion. Int J Oncol. 2015;46(5):2021–8.

    Article  CAS  Google Scholar 

  8. Yu MO, Song N-H, Park K-J, Park D-H, Kim S-H, Chae Y-S, et al. Romo1 is associated with ROS production and cellular growth in human gliomas. J Neurooncol. 2015;121(1):73–81.

    Article  CAS  Google Scholar 

  9. Lee SH, Park MJ, Choi SI, Lee EJ, Lee SY, In KH. Reactive oxygen species modulator 1 (Romo1) as a novel diagnostic marker for lung cancer-related malignant effusion. Medicine. 2017;96(4): e5975.

  10. Käser M, Kambacheld M, Kisters-Woike B, Langer T. Oma1, a novel membrane-bound metallopeptidase in mitochondria with activities overlapping with the m-AAA protease. J Biol Chem. 2003;278(47):46414–23.

    Article  Google Scholar 

  11. Anand R, Wai T, Baker MJ, Kladt N, Schauss AC, Rugarli E, et al. The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission. J Cell Biol. 2014;204(6):919–29.

    Article  CAS  Google Scholar 

  12. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001;25(4):402–8.

    Article  CAS  Google Scholar 

  13. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996;239(1):70–6.

    Article  CAS  Google Scholar 

  14. Yagi K. [39] Assay for blood plasma or serum. In: Methods in enzymology, vol. 105: Elsevier; 1984. p. 328–31.

  15. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103–11.

    Article  CAS  Google Scholar 

  16. Chan K-Y, Wasserman BP. Direct colorimetric assay of free thiol groups and disulfide bonds in suspensions of solubilized and particulate cereal proteins. Cereal Chem. 1993;70:22.

    CAS  Google Scholar 

  17. Wu H, Y-h G, Wei L, Guo T-k, Zhao Y, Su G, et al. Association of Romo1 gene genetic polymorphisms with risk of gastric cancer in northwestern Chinese population. Pathol Oncol Res. 2015;21(3):581–7.

    Article  CAS  Google Scholar 

  18. Sudo G, Nasuno H, Nakachi K, Nakase H. Gastrointestinal: secondary gastric linitis plastica: a peritoneal recurrence of breast cancer. J Gastroenterol Hepatol. 2019. https://doi.org/10.1111/jgh.14725.

  19. Consolato F, Maltecca F, Tulli S, Sambri I, Casari G. m-AAA and i-AAA complexes coordinate to regulate OMA1, the stress-activated supervisor of mitochondrial dynamics. J Cell Sci. 2018;131(7):jcs213546.

    Article  Google Scholar 

  20. Kim HJ, Jo MJ, Kim BR, Kim JL, Jeong YA, Na YJ, et al. Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients. PLoS One. 2017;12(5):e0176834.

    Article  Google Scholar 

  21. Huang Q, Feng J, Wu R, Yang Y, Dai C, Li J, et al. Total oxidant/antioxidant status in sera of patients with esophageal cancer. Med Sci Monit. 2017;23:3789.

    Article  Google Scholar 

  22. Lin S, Li Y, Zamyatnin AA Jr, Werner J, Bazhin AV. Reactive oxygen species and colorectal cancer. J Cell Physiol. 2018;233(7):5119–32.

    Article  CAS  Google Scholar 

  23. Wu R, Feng J, Yang Y, Dai C, Lu A, Li J, et al. Significance of serum total oxidant/antioxidant status in patients with colorectal cancer. PloS One. 2017;12(1):e0170003.

    Article  Google Scholar 

  24. Liu D, Liu Y, Xia Z, Dong H, Yi Z. Reactive oxygen species modulator 1 regulates oxidative stress and induces renal and pulmonary fibrosis in a unilateral ureteral obstruction rat model and in HK-2 cells. Mol Med Rep. 2017;16(4):4855–62.

    Article  CAS  Google Scholar 

  25. Na AR, Chung YM, Lee SB, Park SH, Lee M-S, Do Yoo Y. A critical role for Romo1-derived ROS in cell proliferation. Biochem Biophys Res Commun. 2008;369(2):672–8.

    Article  CAS  Google Scholar 

  26. Kim IG, Kim SY, Kim HA, Kim JY, Lee JH, Im Choi S, et al. Disturbance of DKK1 level is partly involved in survival of lung cancer cells via regulation of ROMO1 and γ-radiation sensitivity. Biochem Biophys Res Commun. 2014;443(1):49–55.

    Article  CAS  Google Scholar 

  27. Setyawan EMN, Kim MJ, Oh HJ, Kim GA, Jo YK, Lee SH, et al. Spermine reduces reactive oxygen species levels and decreases cryocapacitation in canine sperm cryopreservation. Biochem Biophys Res Commun. 2016;479(4):927–32.

    Article  CAS  Google Scholar 

  28. Richter F, Dennerlein S, Nikolov M, Jans DC, Naumenko N, Aich A, et al. ROMO1 is a constituent of the human presequence translocase required for YME1L protease import. J Cell Biol. 2019;218(2):598–614.

    Article  CAS  Google Scholar 

  29. Bohovych I, Dietz JV, Swenson S, Zahayko N, Khalimonchuk O. Redox regulation of the mitochondrial quality control protease Oma1. Antioxid Redox Signal. 2019. https://doi.org/10.1089/ars.2018.7642.

Download references

Acknowledgments

We would like to thank H. Moridi and H. Rezaie and MR. Seyed Rahmani for their assistance. The results presented in this article were part of M.A. Amini MSc thesis.

Funding

This study was financially supported by Hamadan University of Medical Sciences (No: 9709135418).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jamshid Karimi.

Ethics declarations

Ethical Standard

The study protocol was approved by Hamadan University of Medical Sciences Ethics Committee (code: IR.UMSHA.REC.1397.506 approved on 4 Dec 2018).

Conflict of Interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amini, M.A., Karimi, J., Khodadadi, I. et al. Overexpression of ROMO1 and OMA1 are Potentially Biomarkers and Predict Unfavorable Prognosis in Gastric Cancer. J Gastrointest Canc 51, 939–946 (2020). https://doi.org/10.1007/s12029-019-00330-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-019-00330-w

Keywords

Navigation